• SeptiCyte® RAPID receives 510(k) clearance by US FDA

    1 day ago

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    1 day ago

  • Dimitrios Mantzilas joins Precirix as Chief Technology Officer

    1 day ago

  • Lonza and Bioqube Ventures sign a framework agreement for the future development and manufacture of biologics and small molecules for Bioqube’s portfolio companies

    1 day ago

  • Confo Therapeutics enters collaborative agreement with Regeneron

    Tuesday November 30th 2021

  • Mayne Pharma and Mithra announce TGA approval of Nextstellis® oral contraceptive

    Monday November 29th 2021

  • Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

    Monday November 29th 2021

  • S-Biomedic announces topline results of a successful clinical study in acne

    Friday November 26th 2021

  • Your news here?

  • FIT and its 21-strong partner team go all out for more internationalization, growth and prosperity

    Thursday November 25th 2021

  • Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease

    Tuesday November 23rd 2021

  • OXURION NV secures EUR 10 million convertible bond financing from Kreos Capital and Pontifax Ventures

    Monday November 22nd 2021

Strategic Partners